ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 103 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $275,000 | -8.3% | 18,965 | +26.1% | 0.06% | 0.0% |
| Q2 2018 | $300,000 | +23.0% | 15,044 | +51.8% | 0.06% | +43.9% |
| Q4 2017 | $244,000 | -45.7% | 9,908 | -44.3% | 0.04% | -36.9% |
| Q3 2017 | $449,000 | -11.3% | 17,791 | -4.7% | 0.06% | -4.4% |
| Q2 2017 | $506,000 | +25.2% | 18,662 | +37.8% | 0.07% | +25.9% |
| Q1 2017 | $404,000 | +82.0% | 13,546 | +65.5% | 0.05% | +80.0% |
| Q4 2016 | $222,000 | – | 8,183 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |